1-3 of 3
Diego Villa, MD FRCPC
Close
Sort by
Journal Articles

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD, David W. Scott, MBChB, PhD, Diego Villa, MD FRCPC, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Pedro Farinha, MD PhD, Graham W Slack, MD PhD, Don Wilson, MD, R. Petter Tonseth, MD, Joseph M. Connors, MD, Kerry J Savage, BSc, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 401.
https://doi.org/10.1182/blood-2019-128722
Published: 2019
Journal Articles

Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada

Hatem Alahwal, MPH, MBBS, Parv Chapani, Diego Villa, MD FRCPC, Yasser Abou Mourad, MD, Maryse Power, MD, Stephen H. Nantel, MD, David Sanford, MD, Gayatri Sreenivasan, BSc, MD, Heather J. Sutherland, MD PhD, Laurie H Sehn, MD MPH, Cynthia L. Toze, MD FRCPC, MSc, Raewyn Broady, MBChB, Kevin Song, MD, Paul Yenson, MD BSc, FRCPC, Alina S. Gerrie, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 4556.
https://doi.org/10.1182/blood-2018-99-114371
Published: 2018
Journal Articles

A Phase 1 -2 Study of Brentuximab Vedotin (Bv) and Bendamustine (B) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL)

Owen A. O'Connor, MD PhD, John Kuruvilla, MD, Ahmed Sawas, MD, Changchun Deng, MD PhD, Molly Patterson, Joseph M. Connors, MD, Jennifer E Amengual, MD, Michael Crump, MD, Diego Villa, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 3084.
https://doi.org/10.1182/blood.V124.21.3084.3084
Published: 2014